P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS - P. L. Zinzani, MD, PhD; J. Zain, MD; M. Mead, BS, MD; C. Casulo, MD; E. D. Jacobsen, MD; G. Gritti, MD, PhD; L. Pinter-Brown, MD; K. Isutzu, MD; D. Cohan, MD; M. Daugherty, PharmD; J. E. Brammer, MD; N. Mehta-Shah, MD; et al. (HemaSphere, 2022)